DATAROMA
Home
Commentaries/Articles
Superinvestors
Activity
S&P500 Grid
Grand Portfolio
RealTime
Insider
28 Apr 2015
Patent crusade benefits whom?
( Portfolio )
Kyle Bass has challenged patents that drug and biotech companies hold for some of their medicines
Home
Help notes
Contact
Terms of Service
Privacy